Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet Syndrome: Results of the Open-Label Extension Trial (GWPCARE5)

被引:0
作者
Devinsky, O. [1 ]
Nabbout, R. [2 ]
Miller, I. [3 ]
Laux, L. [4 ]
Zolnowska, M. [5 ]
Wright, S. [6 ]
Roberts, C. [6 ]
机构
[1] NYU, Comprehens Epilepsy Ctr, New York, NY USA
[2] Necker Enfants Malad Hosp, Paris, France
[3] Miami Childrens Hosp, Miami, FL USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
[5] Ctr Med Plejady, Krakow, Poland
[6] GW Res Ltd, Cambridge, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
p149
引用
收藏
页码:S73 / S73
页数:1
相关论文
共 50 条
[41]   Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study [J].
Chiorean, Michael ;
Vermeire, Severine ;
Panes, Julian ;
Peyrin-Biroulet, Laurent ;
Zhang, Jinkun ;
Sands, Bruce E. ;
Lazin, Krisztina ;
Cabell, Chris H. ;
Naik, Snehal U. ;
Klassen, Preston ;
Sandborn, William J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 :S445-S446
[42]   Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study [J].
Vermeire, Severine ;
Chiorean, Michael ;
Panes, Julian ;
Peyrin-Biroulet, Laurent ;
Zhang, Jinkun ;
Sands, Bruce E. ;
Lazin, Krisztina ;
Klassen, Preston ;
Naik, Snehal U. ;
Cabell, Christopher H. ;
Sandborn, William J. .
JOURNAL OF CROHNS & COLITIS, 2021, 15 (06) :950-959
[43]   Long-term safety and efficacy of add-on cannabidiol for tuberous sclerosis complex-associated seizures: 3-year results from an open-label extension trial [J].
Sahebkar, F. ;
Thiele, E. A. ;
Bebin, E. M. ;
Filloux, F. ;
Jansen, F. E. ;
Kwan, P. ;
Loftus, R. ;
Sparagana, S. ;
Lawson, J. ;
Wheless, J. .
EPILEPSIA, 2023, 64 :289-290
[44]   Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial [J].
Cutler, Andrew J. ;
Kalali, Amir H. ;
Mattingly, Greg W. ;
Kunovac, Jelena ;
Meng, Xiangyi .
CNS SPECTRUMS, 2013, 18 (01) :43-54
[45]   Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial [J].
Papp, Kim ;
Lebwohl, Mark ;
Puig, Luis ;
Zeng, Jiewei ;
Rubant, Simone ;
Valdes, Joaquin ;
Leonardi, Craig .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB17-AB17
[46]   Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial [J].
Witztum, Joseph L. ;
Gaudet, Daniel ;
Arca, Marcello ;
Jones, Alan ;
Soran, Handrean ;
Gouni-Berthold, Ioanna ;
Stroes, Erik S. G. ;
Alexander, Veronica J. ;
Jones, Richard ;
Watts, Lynnetta ;
Xia, Shuting ;
Tsimikas, Sotirios .
JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) :342-355
[47]   Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension [J].
Keystone, Edward ;
Landewe, Robert ;
van Vollenhoven, Ronald ;
Combe, Bernard ;
Strand, Vibeke ;
Mease, Philip ;
Shaughnessy, Laura ;
VanLunen, Brenda ;
van der Heijde, Desiree .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) :2094-2100
[48]   5-YEAR RESULTS FROM THE RAPID 1 TRIAL AND OPEN-LABEL EXTENSION: LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS [J].
Keystone, E. ;
Landewe, R. ;
van Vollenhoven, R. ;
Combe, B. ;
Strand, V. ;
Mease, P. J. ;
Shaughnessy, L. ;
VanLunen, B. ;
van der Heijde, D. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 :228-229
[49]   PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) [J].
Humbert, M. ;
Mclaughlin, V. V. ;
Gibbs, S. R. ;
Gomberg-Maitland, M. ;
Hoeper, M. ;
Preston, I. R. ;
Souza, R. ;
Waxman, A. B. ;
Ghofrani, H. A. ;
Subias, P. Escribano ;
Feldman, J. P. ;
Bohns Meyer, G. ;
Montani, D. ;
Olsson, K. M. ;
Manimaran, S. ;
Pena, J. de Oliveira ;
Badesch, D. B. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[50]   SUSTAINED EFFICACY AND LONG-TERM SAFETY OF ERENUMAB IN PATIENTS WITH EPISODIC MIGRAINE: RESULTS OF A 5-YEAR, OPEN-LABEL EXTENSION STUDY [J].
Ashina, Messoud ;
Goadsby, Peter J. ;
Reuter, Uwe ;
Silberstein, Stephen ;
Dodick, David W. ;
Xue, Fei ;
Zhang, Feng ;
Cheng, Sunfa ;
Chou, Denise E. ;
Lima, Gabriel Paiva da Silva .
CEPHALALGIA, 2020, 40 :60-61